These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6332815)

  • 1. Regulation of the rate of cell cycle progression in quiescent cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.
    Sekaly RP; MacDonald HR; Nabholz M; Smith KA; Cerottini JC
    J Cell Physiol; 1984 Oct; 121(1):159-66. PubMed ID: 6332815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle regulation of cloned cytolytic T cells by T cell growth factor: analysis by flow microfluorometry.
    Sekaly RP; MacDonald HR; Zaech P; Nabholz M
    J Immunol; 1982 Oct; 129(4):1407-14. PubMed ID: 6980934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of T cell growth factor on the cell cycle of primate T cells.
    Brown RL; Griffith RL; Neubauer RH; Rabin H
    J Immunol; 1982 Nov; 129(5):1849-53. PubMed ID: 6981667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line.
    Stoeck M; Miescher S; MacDonald HR; Von Fliedner V
    J Cell Physiol; 1989 Oct; 141(1):65-73. PubMed ID: 2789227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
    Kanagawa O
    J Immunol; 1983 Aug; 131(2):606-10. PubMed ID: 6602842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective effects of interferon on distinct sites of the T lymphocyte triggering process.
    Leanderson T; Hillörn V; Holmberg D; Larsson EL; Lundgren E
    J Immunol; 1982 Aug; 129(2):490-4. PubMed ID: 6177767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. II. Cell cycle dependency of Epo action.
    Tsuda H; Sawada T; Kawakita M; Takatsuki K
    Exp Hematol; 1989 Mar; 17(3):218-22. PubMed ID: 2917620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitivity of murine T-lymphocyte cytotoxicity.
    Gerber M
    Radiat Res; 1984 Nov; 100(2):365-77. PubMed ID: 6238340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of Tac antigen expressed on activated human T lymphocytes: Tac antigen interacts with T cell growth factor in cellular proliferation.
    Miyawaki T; Yachie A; Uwadana N; Ohzeki S; Nagaoki T; Taniguchi N
    J Immunol; 1982 Dec; 129(6):2474-8. PubMed ID: 6982926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of human normal and leukemic T cells: T-cell growth factor (TCGF) and the isolation of a new class of RNA tumor viruses (HTLV).
    Gallo RC
    Blood Cells; 1981; 7(2):313-29. PubMed ID: 6975142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle.
    Poot M; Teubert H; Rabinovitch PS; Kavanagh TJ
    J Cell Physiol; 1995 Jun; 163(3):555-60. PubMed ID: 7539813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytohemagglutinin-induced human T-lymphocyte colonies: cellular and T-cell growth factor requirements are the same as for suspension culture growth.
    Ruscetti FW
    Nat Immun Cell Growth Regul; 1983-1984; 3(2):102-12. PubMed ID: 6333587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perturbation by insulin of human breast cancer cell cycle kinetics.
    Gross GE; Boldt DH; Osborne CK
    Cancer Res; 1984 Aug; 44(8):3570-5. PubMed ID: 6378371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor.
    Rosenstein M; Eberlein T; Kemeny MM; Sugarbaker PH; Rosenberg SA
    J Immunol; 1981 Aug; 127(2):566-71. PubMed ID: 7019327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent heterogeneity in the response of quiescent swiss 3T3 cells to serum growth factors: implications for the transition probability model and parallels with "cellular senescence" and "competence".
    Brooks RF; Richmond FN; Riddle PN; Richmond KM
    J Cell Physiol; 1984 Nov; 121(2):341-50. PubMed ID: 6333428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
    Radvanyi LG; Shi Y; Mills GB; Miller RG
    Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor.
    Larsson EL
    J Immunol; 1982 Feb; 128(2):742-5. PubMed ID: 6798123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.